Validation of a quantitative RNA PCR assay for HIV-1 in human plasma

Area of Science:

• Virology
• Molecular Biology
• Clinical Diagnostics

Background:

• Accurate quantification of human immunodeficiency virus type 1 (HIV-1) RNA is crucial for monitoring disease progression and treatment efficacy.
• Existing diagnostic methods may have limitations in precision and reproducibility for viral load assessment.

Purpose of the Study:

• To validate a quantitative HIV-1 RNA polymerase chain reaction (PCR) assay for clinical use.
• To assess the assay's precision, reproducibility, and ability to detect viral load changes.

Main Methods:

• Analytical and clinical validation of a quantitative HIV-1 RNA PCR assay.
• Testing on over 13,000 human samples.
• Evaluation of intra- and inter-assay precision.
• Correlation of viral RNA levels with CD4+ counts.
• Assessment of assay's ability to detect viral load reduction compared to p24 antigen assays.

Main Results:

• The assay demonstrated high reproducibility with intra-assay precision of 16% and inter-assay precision of 19%.
• Viral RNA was quantifiable in 1,542 of 1,548 subjects, with levels ranging from approximately 3,000 to 52,200,000 copies/mL.
• Median plasma HIV-1 RNA levels were inversely proportional to CD4+ counts (0-400 cells/mm³).
• The assay could quantify a 10-fold (1 log) viral load reduction in 95% of patients, outperforming p24 antigen assays.

Conclusions:

• The validated quantitative HIV-1 RNA PCR assay is highly reproducible and precise.
• This assay provides a superior method for monitoring viral load in HIV-1 patients.
• The assay's sensitivity enhances the evaluation of antiretroviral therapy efficacy.